These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8106764)

  • 21. Prevention of group B streptococcal colonization with topically applied lipoteichoic acid in a maternal-newborn mouse model.
    Cox F
    Pediatr Res; 1982 Oct; 16(10):816-9. PubMed ID: 6755369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell membrane-binding properties of group A streptococcal lipoteichoic acid.
    Ofek I; Beachey EH; Jefferson W; Campbell GL
    J Exp Med; 1975 May; 141(5):990-1003. PubMed ID: 236356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
    Bessen D; Fischetti VA
    J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Group A streptococci bind to mucin and human pharyngeal cells through sialic acid-containing receptors.
    Ryan PA; Pancholi V; Fischetti VA
    Infect Immun; 2001 Dec; 69(12):7402-12. PubMed ID: 11705914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of lipoteichoic acid on the uptake of Streptococcus pyogenes by HEp-2 cells.
    Sela S; Marouni MJ; Perry R; Barzilai A
    FEMS Microbiol Lett; 2000 Dec; 193(2):187-93. PubMed ID: 11111022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial adherence of group A streptococci to mucosal surfaces.
    Beachey EH; Courtney HS
    Respiration; 1989; 55 Suppl 1():33-40. PubMed ID: 2682867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci.
    Pandey M; Mortensen R; Calcutt A; Powell J; Batzloff MR; Dietrich J; Good MF
    J Immunol; 2016 Apr; 196(8):3364-74. PubMed ID: 26969753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumour effects of streptococcal lipoteichoic acids on Meth A fibrosarcoma.
    Usami H; Yamamoto A; Yamashita W; Sugawara Y; Hamada S; Yamamoto T; Kato K; Kokeguchi S; Ohokuni H; Kotani S
    Br J Cancer; 1988 Jan; 57(1):70-3. PubMed ID: 3279996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a fibronectin-binding protein as adhesin of Streptococcus pyogenes.
    Valentin-Weigand P; Talay SR; Timmis KN; Chhatwal GS
    Zentralbl Bakteriol; 1993 Apr; 278(2-3):238-45. PubMed ID: 8347928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of M protein in adherence of group A streptococci.
    Caparon MG; Stephens DS; Olsén A; Scott JR
    Infect Immun; 1991 May; 59(5):1811-7. PubMed ID: 2019444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against streptococcal pharyngeal colonization with vaccines composed of M protein conserved regions.
    Fischetti VA; Bessen DE; Schneewind O; Hruby DE
    Adv Exp Med Biol; 1991; 303():159-67. PubMed ID: 1805563
    [No Abstract]   [Full Text] [Related]  

  • 32. Hybridoma antibodies against protective and nonprotective antigenic determinants of a structurally defined polypeptide fragment of streptococcal M protein.
    Hasty DL; Beachey EH; Simpson WA; Dale JB
    J Exp Med; 1982 Apr; 155(4):1010-8. PubMed ID: 6174666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical properties and immunobiological activities of streptococcal lipoteichoic acids.
    Hamada S; Yamamoto T; Koga T; McGhee JR; Michalek SM; Yamamoto S
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):228-43. PubMed ID: 3892980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electron microscopic localization of lipoteichoic acid on group A streptococci.
    Rýc M; Wagner B; Wagner M; Bicová R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Aug; 269(2):168-78. PubMed ID: 3057768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.
    Mannam P; Jones KF; Geller BL
    Infect Immun; 2004 Jun; 72(6):3444-50. PubMed ID: 15155651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deposition of circulating streptococcal lipoteichoic acid in mouse tissues.
    Hyzy J; Sciotti V; Albini B; Stinson M
    Microb Pathog; 1992 Aug; 13(2):123-32. PubMed ID: 1453925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A.
    Bessen D; Fischetti VA
    J Exp Med; 1988 Jun; 167(6):1945-50. PubMed ID: 3290383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.
    Brandt ER; Sriprakash KS; Hobb RI; Hayman WA; Zeng W; Batzloff MR; Jackson DC; Good MF
    Nat Med; 2000 Apr; 6(4):455-9. PubMed ID: 10742155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of cellular lipoteichoic acids in mediating adherence of serotype III strains of group B streptococci to human embryonic, fetal, and adult epithelial cells.
    Nealon TJ; Mattingly SJ
    Infect Immun; 1984 Feb; 43(2):523-30. PubMed ID: 6363289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of the binding of streptococcal lipoteichoic acid to human oral epithelial cells.
    Simpson WA; Ofek I; Sarasohn C; Morrison JC; Beachey EH
    J Infect Dis; 1980 Apr; 141(4):457-62. PubMed ID: 6989926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.